Philip Morris to acquire inhaled drug provider Vectura Group for $1.2bn

cafead

Administrator
Staff member
  • cafead   Jul 12, 2021 at 11:12: AM
via Philip Morris International (PMI) has agreed to acquire British pharmaceutical firm Vectura Group for about $1.183bn (£852m) to expand its product pipeline development capabilities in inhaled therapeutics.

article source
 

<